High-throughput closed-loop direct aberration sensing and correction for multiphoton imaging in live animals
Project Number5K99EB034164-02
Former Number1K99NS130153-01
Contact PI/Project LeaderCHEN, XI
Awardee OrganizationCORNELL UNIVERSITY
Description
Abstract Text
Project Summary
This project aims to deliver real-time aberration-corrected multiphoton imaging with improved signal-to-
noise-ratio (SNR) and spatial resolution for studying turbid deep-tissue (~2 mm) of living animals at the cellular
level. Multiphoton microscopy (MPM) has been a useful tool to study biological processes due to its high
specificity and sub-wavelength resolution. Particularly, compared to one-photon imaging, MPM uses excitation
light with a longer wavelength that penetrates deeper into tissues, while the nonlinear process requires a
multiphoton interaction that renders three-dimensional localized excitation. However, the higher-order nonlinear
excitation is more susceptible to focus aberrations, thus, posing a limit for penetration depth in highly scattering
tissues. Adaptive optics (AO) has been a promising tool for aberration sensing and correction for MPM in living
systems. However, two major issues in existing AO methods, 1) accuracy, and 2) speed in aberration sensing,
remain challenging to in vivo real-time deep-tissue imaging.
I propose to develop a new high-throughput direct aberration sensing and correction method for MPM,
termed confocal gradient light interference microscopy (CGLIM). This technique aims to measure the aberrated
wavefront using a common-path, phase-shifting interferometer, to undo the systematic and specimen-induced
aberration which, in turn, will improve the quality of the excitation focus and enhance the signal strength.
Specifically, compared to other efforts, CGLIM uses the long-wavelength (~1.7 μm) elastic backscattered light
from tissues to directly measure the aberrated wavefront of the excitation beam, resulting in substantially lower
power compared to fluorescence techniques and eliminating photodamage, photobleaching, or heating damage
of living systems. Importantly, CGLIM measures the aberrated wavefront only near the focal plane with
nanoscale sensitivity (~2 nm or ~0.002 rad) owing to its common-path, confocal configuration. Furthermore,
CGLIM can validate the accuracy of the aberration sensing by itself via phase conjugation. Lastly, the aberration
correction procedure is directly fed by CGLIM’s measurement in a closed loop without any iterations. CGLIM is
also readily implemented in any laser-scanning system with objectives of different numeric apertures.
With the proposed new method, I will first demonstrate aberration sensing and correction using CGLIM
with tissue phantoms and ex vivo tissue slices. Then, I will combine CGLIM with three-photon (3P) microscopy
to demonstrate aberration-corrected 3P imaging of neuronal activities in live mice and intact adult zebrafish
brains. Finally, I aim to combine the aberration-corrected MPM with the adaptive excitation source and polygon
scanning developed in-house to study real-time neuronal activities in deep regions of live brains, and T cell –
dendritic cell interactions in deep regions of a mouse’s lymph node.
With this project, I hope to establish my research focus on aberration-corrected interferometric
multiphoton imaging for deep tissues in living animals and enable more studies in neuroscience and immunology.
Public Health Relevance Statement
Project Narrative
This research will enable us to study real-time biological processes at the cellular level noninvasively in deep
regions (~2 mm) of living systems. The proposed new method for aberration sensing and correction in highly
scattering tissues will improve the quality of the excitation focus in multiphoton microscopy, thus, will enhance
the signal strength and spatial resolution in deep-tissue imaging. In the long term, this research will allow
scientists to investigate the underpinnings of brain functions and complex behaviors, as well as the mechanism
of immune response in live animals.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
872612445
UEI
G56PUALJ3KT5
CCV3WG2JG248
D4H1NV4APKP3
ELS2M3C6V2S5
EQA8NBEN9WD5
FFAZGE9NH3M8
K6JRCJJXFET1
M8FBSLHASMT3
P4LRVQT1H4K5
PJUVN8AT5416
RT1JPM9UMGM5
ZBMGUAZYFGC4
ZMP8BDLJTUW9
Project Start Date
01-March-2023
Project End Date
31-May-2025
Budget Start Date
01-March-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$104,125
Direct Costs
$96,412
Indirect Costs
$7,713
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$104,125
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K99EB034164-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K99EB034164-02
Patents
No Patents information available for 5K99EB034164-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K99EB034164-02
Clinical Studies
No Clinical Studies information available for 5K99EB034164-02
News and More
Related News Releases
No news release information available for 5K99EB034164-02
History
No Historical information available for 5K99EB034164-02
Similar Projects
No Similar Projects information available for 5K99EB034164-02